Davide Fattore

European recommendations for management of immune checkpoint inhibitors‐derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement

Zoé Apalla, Vasiliki Nikolaou, Davide Fattore et al. · Journal of the European Academy of Dermatology and Venereology · 2021 · 99 citations · Full text

Medicine, Dermatology, Oncology +17

Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group

Vasiliki Nikolaou, V. Sibaud, Davide Fattore et al. · Journal of the American Academy of Dermatology · 2020 · 87 citations

Life Sciences, Dermatology, Immunology +17

Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors

Pietro Sollena, Vasiliki Nikolaou, Nikolaos Soupos et al. · Breast Cancer Research and Treatment · 2020 · 43 citations

Medicine, Oncology, Pharmacology +15

Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients

Vasiliki Nikolaou, Zoé Apalla, Cristina Carrera et al. · British Journal of Dermatology · 2022 · 42 citations · Full text

Medicine, Dermatology, Oncology +17

Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study

Pietro Sollena, Vasiliki Nikolaou, Alexander Stratigos et al. · Cancers · 2023 · 29 citations · Full text

Medicine, Dermatology, Oncology +16